Asian Pacific Journal of Cancer Prevention

  • 제13권5호
  • /
  • Pages.2145-2148
  • /
  • 2012
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

PBK/TOPK Expression During TPA-Induced HL-60 Leukemic Cell Differentiation

  • Liu, Yu-Hong (Department of Hematology, The Affiliated Hospital of Yan'an University) ;
  • Gao, Xue-Mei (Department of Hematology, The Affiliated Hospital of Yan'an University) ;
  • Ge, Fan-Mei (Department of Hematology, The Affiliated Hospital of Yan'an University) ;
  • Wang, Zhe (Department of Pathology, School of Basic Medicine, Fourth Military Medical University) ;
  • Wang, Wen-Qing (Department of Pathology, School of Basic Medicine, Fourth Military Medical University) ;
  • Li, Xiao-Yong (Department of General Surgery, The Affiliated Hospital of Yan'an University)
  • 발행 : 2012.05.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: This study concerns expression of PBK/TOPK during differentiation of HL-60 leukemic cells induced by tetradecanoyl phorbol acetate (TPA). Methods: Wright-Giemsa staining was performed to observe morphological changes in the HL-60 cells, and flow cytometry was used to assess the cell cycle and CD11b, CD14, CD13, and CD33 expression. PBK/TOPK levels were determined by Western blot analysis. Results: After treating HL60 cells with $5.1{\times}10^{-9}$ mmol/L of TPA for three days, the number of nitroblue-tetrazolium-positive cells and CD11b, CD13, and CD14 expression increased, whereas the PBK/TOPK levels decreased. Conclusions: TPA can inhibit proliferation and induce differentiation of HL60 cells of the granulocytic or monocytic lineage. PBK/TOPK expression was downregulated during this process, whereas the Pho-PBK/TOPK expression was increased.

키워드

참고문헌

  1. Abe Y, Matsumoto S, Kito K, et al (2000). Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. J Biol Chem, 275, 21525-31. https://doi.org/10.1074/jbc.M909629199
  2. Ayllon V, O'connor R (2007). PBK/TOPK promotes tummor cell proliferation through P38 MAPK activity and regulation of the DNA damage response. Oncogene, 26, 3451-61. https://doi.org/10.1038/sj.onc.1210142
  3. Beltran JA, Peek J, Chang SL (2006). Expression and regulation of the mu opioid peptide receptor in TPA-differentiated HL-60 promyelocytic leukemia cells. Int Immunopharmacol, 6, 1331-40. https://doi.org/10.1016/j.intimp.2006.03.017
  4. Cote S, Simard C, Lemieux R (2002). Regulation of growthrelated genes by interleukin-6 in murine myeloma cells. Cytokine, 20, 113-20. https://doi.org/10.1006/cyto.2002.1988
  5. Dong C, Davis RJ, Flavell RA (2001). Signaling by the JNK group of MAP kinases. c-jun N-terminal Kinase. J Clin Immunol, 21, 253-7. https://doi.org/10.1023/A:1010975124110
  6. Drew BA, Burow ME, Beckman BS (2012). MEK5/ERK5 pathway: the first fifteen years. Biochim Biophys Acta, 1825, 37-48.
  7. Gaudet S, Branton D, Lue RA (2000). Characterization of PDZbinding kinase, a mitotic kinase. Proc Natl Acad Sci U S A, 97, 5167-72. https://doi.org/10.1073/pnas.090102397
  8. He F, Yan Q, Fan L, et al (2010). PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma. Hum Pathol, 41, 415-24. https://doi.org/10.1016/j.humpath.2009.05.016
  9. Huang S, Shen Q, Mao WG, et al (2006). JWA, a novel signaling molecule, involved in all-trans retinoic acid induced differentiation of HL-60 cells. J Biomed Sci, 13, 357-71. https://doi.org/10.1007/s11373-005-9068-0
  10. Kobel M, Pohl G, Schmitt WD, et al (2005). Activation of mitogen-activated protein kinase is required for migration and invasion of placental site trophoblastic tumor. Am J Pathol, 167, 879-85. https://doi.org/10.1016/S0002-9440(10)62059-7
  11. Liu J, Lei DP, Jin T, et al (2011). Altered expression of miR- 21 and PTEN in human laryngeal and hypopharyngeal squamous cell carcinomas. Asian Pac J Cancer Prev, 12, 2653-7.
  12. Liu P, Wang X, Hu C, Hu T (2011). Inhibition of proliferation and induction of apoptosis by trimethoxyl stilbene (TMS) in a lung cancer cell line. Asian Pac J Cancer Prev, 12, 2263-9.
  13. Macfarlane DE, Manzel L (1994). Activation of $\beta$-isozyme of protein kinase C($PKC{\beta}$) is necessary and sufficient for phorbol ester induced differdentiation of HL-60 promyelocytes. J Biol Chem, 269, 4327-31.
  14. Meinhardt G, Eppinger E, Schmidmaier R (2002). Effect of novel modulators of protein kinase C activity upon kinase activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemia cells. Anticancer Drugs, 13, 725-31. https://doi.org/10.1097/00001813-200208000-00007
  15. Nandi A, Tidwell M, Karp J, et al (2004). Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells. Blood Cells Mol Dis, 32, 240-5. https://doi.org/10.1016/j.bcmd.2003.10.004
  16. Nandi AK, Rapoport AP (2006). Expression of PDZbinding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF. Leuk Res, 30, 437-47. https://doi.org/10.1016/j.leukres.2005.08.011
  17. Nakaya K, Nabata Y, Ichiyanagi T, et al (2012). Stimulation of dendritic cell maturation and induction of apoptosis in leukemia cells by a heat-stable extract from azuki bean (vigna angularis), a promising immunopotentiating food and dietary supplement for cancer prevention. Asian Pac J Cancer Prev, 13, 607-11. https://doi.org/10.7314/APJCP.2012.13.2.607
  18. Obata T, Brown GE, Yaffe MB (2000). MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med, 28, N67-77. https://doi.org/10.1097/00003246-200001000-00011
  19. Park JH, Lin ML, Nishidate T, et al (2006). PDZ-binding kinase/T-LAK cell originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. Cancer Res, 66, 9186-95. https://doi.org/10.1158/0008-5472.CAN-06-1601
  20. Raviv Z, Kalie E, Seger R (2004). MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation. J Cell Sci, 117, 1773-84. https://doi.org/10.1242/jcs.01040
  21. Reddy KB, Nabha SM, Atanaskova N (2003). Role of MAPkinase in tumor progression and invasion. Cancer Metastasis Rev, 22, 395-403. https://doi.org/10.1023/A:1023781114568
  22. Simons-Evelyn MK, Bailey D, Toretsky JA, et al (2001). PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells. Blood Cells Mol Dis, 27, 825-9. https://doi.org/10.1006/bcmd.2001.0452
  23. Yamamoto S, Tamai H, Ishisaka R, et al (2000). Mechanism of alpha-tocopheryl succinate-induced apoptosis of promyelocytic leukemia cell. Free Radic Res, 33, 407-18. https://doi.org/10.1080/10715760000300941
  24. Yuryev A, Wennogle LP (2003). Novel Raf kinase proteinprotein interactions found by an exhaustive yeast two-hybrid analysis. Genomics, 81, 112-5. https://doi.org/10.1016/S0888-7543(02)00008-3

피인용 문헌

  1. Alternol inhibits the proliferation and induces the differentiation of the mouse melanoma B16F0 cell line vol.36, pp.2, 2016, https://doi.org/10.3892/or.2016.4844